Literature DB >> 27895771

Co-culture of hepatoma cells with hepatocytic precursor (stem-like) cells inhibits tumor cell growth and invasion by downregulating Akt/NF-κB expression.

Cheng-Jun Sui1, Miao Xu2, Wei-Qing Li3, Jia-Mei Yang1, Hong-Zhu Yan3, Hui-Min Liu3, Chun-Yan Xia3, Hong-Yu Yu3.   

Abstract

Hepatocytic stem cells (HSCs) have inhibitory effects on hepatocarcinoma cells. The present study investigated the effects of HSC activity in hepatocarcinoma cells in vitro. A Transwell co-culture system of hepatocytic precursor (stem-like) WB-F344 cells and hepatoma CBRH-7919 cells was used to assess HSC activity in metastasized hepatoma cells in vitro. Nude mouse xenografts were used to assess HSC activity in vivo. Co-culture of hepatoma CBRH-7919 cells with WB-F344 cells suppressed the growth and colony formation, tumor cell migration and invasion capacity of CBRH-7919 cells. The nude mouse xenograft assay demonstrated that the xenograft size of CBRH-7919 cells following co-culture with WB-F344 cells was significantly smaller compared with that of control cells. Furthermore, the expression levels of the epithelial markers E-cadherin and β-catenin were downregulated, while the mesenchymal markers α-SMA and vimentin were upregulated. Co-culture of CBRH-7919 cells with WB-F344 cells downregulated NF-κB and phospho-Akt expression. In conclusion, hepatocytic precursor (stem-like) WB-F344 cells inhibited the growth, colony formation and invasion capacity of metastasized hepatoma CBRH-7919 cells in vitro and in vivo by downregulating Akt/NF-κB signaling.

Entities:  

Keywords:  Akt/NF-κB signaling pathway; cancer metastasis; hepatocytic precursor (stem-like) cells; hepatoma cells

Year:  2016        PMID: 27895771      PMCID: PMC5104234          DOI: 10.3892/ol.2016.5128

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  42 in total

1.  Differentiation therapy exerts antitumor effects on stem-like glioma cells.

Authors:  Benito Campos; Feng Wan; Mohammad Farhadi; Aurélie Ernst; Felix Zeppernick; Katrin E Tagscherer; Rezvan Ahmadi; Jennifer Lohr; Christine Dictus; Georg Gdynia; Stephanie E Combs; Violaine Goidts; Burkhard M Helmke; Volker Eckstein; Wilfried Roth; Philipp Beckhove; Peter Lichter; Andreas Unterberg; Bernhard Radlwimmer; Christel Herold-Mende
Journal:  Clin Cancer Res       Date:  2010-05-04       Impact factor: 12.531

Review 2.  Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma.

Authors:  J B Aquino; M F Bolontrade; M G García; O L Podhajcer; G Mazzolini
Journal:  Gene Ther       Date:  2010-03-11       Impact factor: 5.250

Review 3.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

4.  A diploid epithelial cell line from normal adult rat liver with phenotypic properties of 'oval' cells.

Authors:  M S Tsao; J D Smith; K G Nelson; J W Grisham
Journal:  Exp Cell Res       Date:  1984-09       Impact factor: 3.905

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases.

Authors:  K Yuki; S Hirohashi; M Sakamoto; T Kanai; Y Shimosato
Journal:  Cancer       Date:  1990-11-15       Impact factor: 6.860

7.  Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line.

Authors:  Guo-Cai Li; Qing-Hai Ye; Yu-Hua Xue; Hai-Jing Sun; Hai-Jun Zhou; Ning Ren; Hu-Liang Jia; Jiong Shi; Jin-Cai Wu; Chun Dai; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  Cancer Sci       Date:  2010-10-07       Impact factor: 6.716

Review 8.  Epithelial-mesenchymal transitions: twist in development and metastasis.

Authors:  Yibin Kang; Joan Massagué
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

9.  Retroviral vector-producing mesenchymal stem cells for targeted suicide cancer gene therapy.

Authors:  Ryosuke Uchibori; Takashi Okada; Takayuki Ito; Masashi Urabe; Hiroaki Mizukami; Akihiro Kume; Keiya Ozawa
Journal:  J Gene Med       Date:  2009-05       Impact factor: 4.565

10.  Selective tropism of liver stem cells to hepatocellular carcinoma in vivo.

Authors:  Xiao-Gang Zhong; Sheng He; Wu Yin; Jing-Yu Deng; Bo Cheng
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.